1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Government Initiatives for Proper Disposal of Medications
4.2.2 Rising Awareness Regarding Pharmaceuticals Waste
4.2.3 Expanding Patient Population
4.3 Market Restraints
4.3.1 High Cost Associated with Disposal of Pharmaceutical Waste
4.3.2 Reluctance in the Adoption of New Technologies
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type of Waste
5.1.1 Prescription Drugs
5.1.2 Over the Counter Waste
5.1.3 Others
5.2 By Waste Generator Type
5.2.1 Hospitals/Clinics
5.2.2 Biopharmaceutical Companies
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BioMedical Waste Solutions, LLC
6.1.2 Clean Harbors, Inc.
6.1.3 Covanta Holding Corporation
6.1.4 Sharps Compliance, Inc.
6.1.5 Stericycle
6.1.6 Suez SA
6.1.7 US Ecology, Inc.
6.1.8 Waste Management, Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS